$76.99▴ 0.03%
End-of-day close · 2026-08-26
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Forte Biosciences, Inc. 's earnings-quality signal is not available yet.
Key numbers
Recent news
argenx Completes Acquisition of Forte Biosciences, Inc.
Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their Shareholders